After PTAB Declined to Institute IPR, Defendant Able to Invalidate Patent on Summary Judgment

Jun 3, 2015

Reading Time : 2 min

The defendant, Safeway, attempted to institute the IPR after the plaintiff, Kroy, sued Safeway and several other grocery stores for infringing its patented smart rewards card technology. The Patent Trial and Appeal Board (PTAB) declined to institute the IPR, finding that Safeway failed to show that the patent was likely invalid as anticipated and obvious based on the asserted prior art (two patents). Later, at the district court, Safeway relied on two different patents in a motion for summary judgment of invalidity, again arguing that the asserted patent was anticipated and obvious. Safeway also filed a separate motion for summary judgment of invalidity based on ineligible subject matter under section 101, based on the Supreme Court’s decisions in Alice Corp. Pty. Ltd. v. CLS Bank International, 134 S. Ct. 2347 (2014).

In granting the summary judgment based on ineligible subject matter, Judge Bryson reiterated the position of the Supreme Court in Alice that abstract ideas do not become patentable simply by implementing the idea with a computer. Noting that the “core idea” of Kroy’s patent, an incentive­based rewards program, is “plainly an unpatentable abstract idea,” Bryson held that “[u]sing a computer and a computer­based network to provide and operate such [a program] does not render the idea any less abstract or any more patentable.” Bryson rejected Krol’s argument that the patent itself pertains to the mass rewards card system, finding that the patent’s claims do not support this theory.

Remarkably, in a separate opinion, Bryson also granted a separate motion for summary judgment based on anticipation and obviousness. While the Alice invalidity defense is unavailable in IPR proceedings, Safeway had already asserted section 102 and 103 defenses to the PTAB. Under section 315(e)(2), “the petitioner in an inter partes review of a claim in a patent under this chapter that results in a final written decision . . . may not assert . . . in a civil action . . . that the claim is invalid on any ground that the petitioner raised . . . during that inter partes review” (emphasis added). Thus, at first glance section 315 estopped Safeway from asserting anticipation and obviousness again. However, since the PTAB denied institution based on a lack of reasonable likelihood that Safeway would prove invalidity, the review process did not reach the final determination phase and, thus the claim did not “result in a final written decision.” Thus, Safeway was able to present an invalidity defense that was adopted by the trial court.

Kroy IP Holdings, LLC. v. Safeway, Inc., No. 2:12­cv­800­WCB (E.D. Tex.).

Share This Insight

Categories

Previous Entries

IP Newsflash

October 1, 2025

In a recent final written decision, the PTAB determined that a reference patent was not prior art, despite the petitioner’s post‑filing attempt to correct its petition. While the petitioner argued that it intended to rely on the patent application’s earlier date of publication, both the corrected petition and the expert declaration continued to reference the issued patent rather than the published application.

...

Read More

IP Newsflash

September 30, 2025

The USPTO Director recently granted a petitioner’s request for rehearing of the decision discretionarily denying institution of inter partes review, ultimately vacating the original decision, and referring the petition to the board for an institution decision.

...

Read More

IP Newsflash

September 25, 2025

In considering claims to a method of reducing cardiovascular events, the Federal Circuit held that the term a “clinically proven effective” amount did not render the claims patentable over the prior art. Specifically, the Federal Circuit held that the “clinically proven effective” amount, whether limiting or not, could not be used to distinguish the prior art because the claims also specified the exact amount of the drugs to be administered in the method. The Federal Circuit also rejected patentee’s evidence of unexpected results because that evidence was tied solely to the “clinically proven effective” limitation.

...

Read More

IP Newsflash

September 24, 2025

The Federal Circuit reversed a district court’s denial of judgment as a matter of law on non-infringement, thereby setting aside a $106 million jury verdict, after holding that prosecution history estoppel barred the patentee from asserting infringement under the doctrine of equivalents.

...

Read More

IP Newsflash

September 17, 2025

A magistrate judge in the District of Delaware issued a Report and Recommendation, that found the sole asserted claim was a “single means” claim and therefore invalid for lack of enablement. In reaching that conclusion, the magistrate judge rejected the patentee’s argument that the preamble of the claim disclosed a second element that satisfied the combination requirement of Section 112, paragraph 6 because the preamble simply recited a descriptor of the very apparatus that was the subject of the means-plus-function limitation in the body of the claim. The district court judge presiding over this case has scheduled a hearing to review the magistrate’s ruling.

...

Read More

IP Newsflash

September 9, 2025

The Federal Circuit has affirmed the PTAB’s determination that a patent challenger did not show the challenged claims were unpatentable for obviousness. The Federal Circuit concluded that substantial evidence, which included expert testimony, showed there was no motivation to combine the references.

...

Read More

IP Newsflash

August 29, 2025

In a recent order addressing four IPR proceedings, the PTAB exercised its inherent authority under 37 C.F.R. § 42.5(a) to sua sponte authorize post-hearing discovery on a potentially dispositive privity issue. The order followed a Director review decision that vacated and remanded earlier IPRs involving the same parties, patent family, and privity issue. 

...

Read More

IP Newsflash

August 29, 2025

The Patent Trial and Appeal Board denied institution of an inter partes review petition in part because it determined that a patent reference was not prior art under the common ownership exception of pre-AIA 35 U.S.C. § 103(c)(1).

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.